Published in Cancer Weekly, October 6th, 1997
Specifically, the committee voted in favor of approving Photofrin for the treatment of endobronchial microinvasive non-small cell lung cancer (NSCLC) in patients for whom surgery and radiotherapy are not indicated.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.